Evidence map›Paper›PMID 34746205›Full record

ArticleFrontiers in nutrition2021

Effects of Nisin, Cecropin, and

Famin Ke, Peijuan Xie, Yanrong Yang, Liu Yan, Ailing Guo, Jian Yang, Jing Zhang, Li Liu, Qin Wang, Xiaowei Gao

Open access · goldAbstract read
In one paragraph

Article in Frontiers in nutrition, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Gut microbiome, metabolome and alopecia areata.Frontiers in microbiology · 2023
    Review
  13. An Updated Review on Efficiency ofBioMed research international · 2023
    Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Famin KeSchool of Pharmacy, Southwest Medical University, Luzhou, China.
Peijuan XieSchool of Pharmacy, Southwest Medical University, Luzhou, China.
Yanrong YangSchool of Pharmacy, Southwest Medical University, Luzhou, China.
Liu YanSchool of Pharmacy, Southwest Medical University, Luzhou, China.
Ailing GuoSchool of Pharmacy, Southwest Medical University, Luzhou, China.
Jian YangSchool of Pharmacy, Southwest Medical University, Luzhou, China.
Jing ZhangSchool of Pharmacy, Southwest Medical University, Luzhou, China.
Li LiuSchool of Pharmacy, Southwest Medical University, Luzhou, China.
Qin WangSchool of Pharmacy, Southwest Medical University, Luzhou, China.
Xiaowei GaoSchool of Pharmacy, Southwest Medical University, Luzhou, China.
Southwest Medical University · CNAffiliated Hospital of Southwest Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following a ban on antibiotic use in the feed industry, trials on the effects of various immunostimulants (prebiotics, probiotics, antimicrobial peptides [AMPs], and herbs) on the survival, growth, immunity, and disease control of farmed fish in aquaculture are being rapidly conducted. The wide variety of microbes with roles in nutrition, metabolism, and immunity in the fish intestine is the primary factor affecting the fermentability and functionality of dietary immunostimulants. For this reason, the dynamic interactions between immunostimulants and the intestinal microbiome may influence fish health. In this study, the effects of two agriculturally important AMPs (nisin and cecropin) and one herb (

Indexed as

cecropincommon carpfeed additivesintestinal microbiomenisinPenthorum chinense pursh

Identifiers

PMID34746205
PMCPMC8566669
OpenAlexW3208438539

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.